Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF – Get Free Report) is one of 178 public companies in the “Medical Devices” industry, but how does it weigh in compared to its competitors? We will compare Drägerwerk AG & Co. KGaA to similar companies based on the strength of its risk, institutional ownership, analyst recommendations, earnings, dividends, profitability and valuation.
Institutional and Insider Ownership
13.9% of Drägerwerk AG & Co. KGaA shares are held by institutional investors. Comparatively, 39.2% of shares of all “Medical Devices” companies are held by institutional investors. 21.1% of shares of all “Medical Devices” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Drägerwerk AG & Co. KGaA and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Drägerwerk AG & Co. KGaA||N/A||N/A||7.18|
|Drägerwerk AG & Co. KGaA Competitors||$868.47 million||$76.73 million||65.03|
This is a summary of recent ratings and price targets for Drägerwerk AG & Co. KGaA and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Drägerwerk AG & Co. KGaA||1||0||0||0||1.00|
|Drägerwerk AG & Co. KGaA Competitors||378||1506||2777||116||2.55|
As a group, “Medical Devices” companies have a potential upside of 74.35%. Given Drägerwerk AG & Co. KGaA’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Drägerwerk AG & Co. KGaA has less favorable growth aspects than its competitors.
This table compares Drägerwerk AG & Co. KGaA and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Drägerwerk AG & Co. KGaA||N/A||N/A||N/A|
|Drägerwerk AG & Co. KGaA Competitors||-85.99%||-145.06%||-17.33%|
Drägerwerk AG & Co. KGaA competitors beat Drägerwerk AG & Co. KGaA on 8 of the 11 factors compared.
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.